Kazia Therapeutics (KZIA) EPS (Basic) (2009 - 2011)

Kazia Therapeutics (KZIA) reported EPS (Basic) of -$0.01 for Q4 2011, up 82.41% on a YoY basis from -$0.0 in Q4 2010, and up 82.41% quarter-over-quarter from -$0.04 in Q4 2010.

Kazia Therapeutics (KZIA) EPS (Basic) (2009 - 2011) Analysis & Trends

Kazia Therapeutics has reported EPS (Basic) for 3 years, with the latest figure at -$0.01 in Q4 2011.

  • For the quarter ending Q4 2011, EPS (Basic) rose 82.41% year-over-year to -$0.01; the trailing twelve-month figure through Aug 2013 stood at -$0.01 (changed N/A YoY), and the FY2025 full-year result was -$0.02, up 63.84% from the prior year.
  • EPS (Basic) for Q4 2011 stood at -$0.01, up from -$0.04 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.01 in Q4 2011, with the low at -$0.05 in Q4 2009.
  • Historically, EPS (Basic) has averaged -$0.03 across 3 years, with a median of -$0.03 in 2009.
  • Annual changes were most pronounced in 2010 — EPS (Basic) increased 18.56% — and 2011, when it surged 82.41%.
  • Kazia Therapeutics' EPS (Basic) stood at -$0.05 in 2009, then climbed by 18.56% to -$0.04 in 2010, then surged by 82.41% to -$0.01 in 2011.
  • The last three EPS (Basic) figures came in at -$0.01 (Q4 2011), -$0.04 (Q4 2010), and -$0.05 (Q4 2009), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -0.68
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 3.06
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 0.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 0.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 4.06
9 Abivax 91.96 Bn 91.96 Bn - -0.06
10 Kazia Therapeutics 1.70 Bn 1.70 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2011 -0.01
Dec 31, 2010 -0.04
Dec 31, 2009 -0.05
Jun 30, 2009 -0.02